Basel Medical Group Ltd Description Of Growth Rate Used To Extrapolate Cash Flow Projections
Basel Medical Group Ltd (BMGL) had Description Of Growth Rate Used To Extrapolate Cash Flow Projections of 2.00% as of 2025-06-30, per its 20-F/A filed 2026-03-13.
Financial Statements › Notes
ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections · last filed 2026-03-13
- 2025-06-30: Description Of Growth Rate Used To Extrapolate Cash Flow Projections 2.00%.
| Period end | Description Of Growth Rate Used To Extrapolate Cash Flow Projections |
|---|---|
| 2025-06-30 | 2.00% 20-F/A · filed 2026-03-13 |